Bayer Tells High Court To Curb Flanax Fight Again

By Andrew Karpan (October 13, 2021, 8:05 PM EDT) -- Bayer AG has assured the U.S. Supreme Court that nothing close to a circuit split hangs over its decade-plus efforts to sue a small American drugmaker in a fight that centers on who owns the trademark of a Mexican brand name the pharmaceutical giant has never used in the U.S.

The brief came on Tuesday, right on the extended deadline Bayer requested in late August in the latest round of its long-winding legal fight with Belmora LLC, a small Virginia company that markets a pain medication using the brand "Flanax," the same name Bayer uses to sell a similar medication in...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!